Showing results (31-40 of 3,180) with videos related to

Sort By:
Pageof 318
Molecular Cancer Research : MCR|February 12, 2009
Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapyHisani N Horne, Paula S Lee, Susan K Murphy, et al.
Molecular Cancer Research : MCR|February 12, 2009
KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of originChanjuan Shi, Seung-Mo Hong, Phillip Lim, et al.
Molecular Cancer Research : MCR|February 12, 2009
Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signalingAnthony Ambesi, Paula J McKeown-Longo
Molecular Cancer Research : MCR|August 11, 2010
Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancerPaolo Ceppi, Giridhar Mudduluru, Regalla Kumarswamy, et al.
Molecular Cancer Research : MCR|July 22, 2010
Deletion at fragile sites is a common and early event in Barrett's esophagusLisa A Lai, Rumen Kostadinov, Michael T Barrett, et al.
Molecular Cancer Research : MCR|November 5, 2010
Context-dependent bidirectional regulation of the MutS homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cellsYang Yu, Yujun Wang, Xiubao Ren, et al.
Molecular Cancer Research : MCR|November 5, 2010
HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genesSunshine Daddario Axlund, James R Lambert, Steven K Nordeen
Molecular Cancer Research : MCR|March 16, 2011
JAG2 induction in hypoxic tumor cells alters Notch signaling and enhances endothelial cell tube formationAlexander Pietras, Kristoffer von Stedingk, David Lindgren, et al.
Molecular Cancer Research : MCR|April 12, 2011
A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expressionChen-Yin Ou, Melissa J LaBonte, Philipp C Manegold, et al.
Molecular Cancer Research : MCR|April 12, 2011
Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cellsDun Li, Natalia D Marchenko, Ramona Schulz, et al.
Pageof 318